Evidence map›Paper›PMID 35130874›Full record

ArticleBMC neurology2022

Novel detection of mutation in the TECPR2 gene in a Chinese hereditary spastic paraplegia 49 patient: a case report.

Yalin Guan, Hui Lu, Wenchao Zuo, Xiaodan Wang, Shimin Wang, Xinping Wang, Feng Liu, Kun Jia, Rui Gao, Hao Wu and 2 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Yalin GuanDepartment of Neurology, Tianjin Huanhu Hospital, Tianjin, 300350, China. guanyalintj@126.com.ORCID http://orcid.org/0000-0002-8892-8422
Hui LuDepartment of Neurology, Tianjin Huanhu Hospital, Tianjin, 300350, China.
Wenchao ZuoDepartment of Neurology, Tianjin Huanhu Hospital, Tianjin, 300350, China.
Xiaodan WangDepartment of Neurology, Tianjin Huanhu Hospital, Tianjin, 300350, China.
Shimin WangDepartment of Neurology, Tianjin Huanhu Hospital, Tianjin, 300350, China.
Xinping WangDepartment of Neurology, Tianjin Huanhu Hospital, Tianjin, 300350, China.
Feng LiuDepartment of Neurology, Tianjin Huanhu Hospital, Tianjin, 300350, China.
Kun JiaDepartment of Neurology, Tianjin Huanhu Hospital, Tianjin, 300350, China.
Rui GaoDepartment of Neurology, Tianjin Huanhu Hospital, Tianjin, 300350, China.
Hao WuDepartment of Neurology, Tianjin Huanhu Hospital, Tianjin, 300350, China.
Zhihong ShiDepartment of Neurology, Tianjin Huanhu Hospital, Tianjin, 300350, China.
Yong JiDepartment of Neurology, Tianjin Huanhu Hospital, Tianjin, 300350, China.
Tianjin Huanhu Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHereditary spastic paraplegia 49 (HSP49) is an autosomal recessive genetic disease first discovered in 2012; and which the mutation primarily affects Bukharian Jewish patients. CASE PRESENTATION: The present case reports the first instance of HSP49 detected in China. The patient had normal mental development and good athletic ability before 10 years old and presented with instable temperature, mental retardation, spastic ataxia, and paroxysmal convulsions. Genetic diagnosis was based on detection of whole exons and two heterozygous variants in the exon region of the TECPR2 gene: c.1729C > T and c.4189G > A. Mutations at these two sites have not been previously reported.

conclusionsThis case expands the gene mutation spectrum and clinical phenotypic characteristics of autosomal recessive HSP in China; moreover, it indicates differences in the clinical phenotype of HSP49 in different ethnicities. In addition, this reported provides further evidence regarding the effectiveness of targeted next-generation sequencing technology in improving the efficiency and diagnostic rate of genetic diagnosis of HSP.

Indexed as

Optic AtrophySpastic Paraplegia, HereditarySpinocerebellar AtaxiasAsian PeopleCarrier ProteinsChildHumansMutationNerve Tissue ProteinsPedigreeCarrier ProteinsNerve Tissue ProteinsTECPR2 protein, humanAutosomal recessive inherited diseaseCase reportHereditary spastic paraplegiaHeterozygous mutationsSpastic ataxia

Identifiers

PMID35130874
PMCPMC8819938
OpenAlexW4210258050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.